(Q53914259)

English

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

G O N Oosterhof

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

J T Roberts

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

Th M de Reijke

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

S A Engelholm

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

S Horenblas

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

H von der Maase

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

N Neymark

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

M Debois

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

L Collette

9

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

European Urology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

44

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

519-526

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative irradiation of bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Strontium-89 treatment for prostate cancer bone metastases: does a prostate-specific antigen response predict for improved survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900364-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0302-2838(03)00364-6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14572748

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53914259&oldid=2098713702"